SCHEMBL7063136

SCHEMBL7063136

Cc1[nH]c2c(O)ccnc2c1C(=O)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
KDM4A O75164 1/20 0.33
RAB9A P51151 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
HIF1AN Q9NWT6 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 3/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX5 P09917 1/20 0.32
GAA P10253 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM5A P29375 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12817480 0.88 KDM4E (0.37) KDM4EKDM4ARAB9AEGLN1HIF1AN
SCHEMBL1763382 0.84 KDM5A (0.39) KDM4EKDM4AMAPTGAAKDM5A
SCHEMBL1763903 0.75 DYRK1A (0.35) KDM4EMAPTMEN1ALDH1A1CYP1A2
SCHEMBL7064351 0.74 ADORA3 (0.41) RAB9AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL7063087 0.72 DYRK1A (0.34) KDM4ERAB9AL3MBTL1MAPTMEN1
SCHEMBL6356783 0.72 DYRK1A (0.39) KDM4EKDM4ARAB9AMAPTMEN1
SCHEMBL12817477 0.71 KDM5A (0.44) KDM4EKDM4AALDH1A1KDM5AKDM4C
SCHEMBL6433898 0.69 KDM4C (0.45) KDM4EKDM4ARAB9AEGLN1HIF1AN
SCHEMBL7058474 0.65 AURKA (0.42) RAB9AMAPTALDH1A1
SCHEMBL1763315 0.64 DAO (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030181463-A1 Antiviral azaindole derivatives VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030181463-A1 Antiviral azaindole derivatives ZC3HAV1, MAVS, AZI2 KDM4E 462/4885KDM4A 315/4885RAB9A 1982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.